Prakt. lékáren. 2022; 18(3): 151-154 | DOI: 10.36290/lek.2022.031

Haemorrhoidal disease or another problem?

Martin Kouda1, Gabriela Kroupová2
1 Chimare clinic, s. r. o., a Chirurgická klinika 2. LF UK a FN Motol, Praha
2 Lékárna AVE Olomouc

A pharmacist is typically the first healthcare professional to be consulted by a patient with haemorrhoidal disease. In order to be able to advise accordingly, he or she should know how to communicate with such a patient. Acute perianal thrombosis and haemorrhoidal disease with all its four stages must be distinguished. It is also important to inquire about the bleeding and its character since it may be a manifestation of a more serious condition. Comprehensive management for haemorrhoidal disease includes topical treatment that must be chosen appropriately, with patient education on its administration. According to current recommendations, venoactive drugs are the mainstay of treatment of haemorrhoidal disease, of which the micronized purified flavonoid fraction has the broadest mechanism of action. The pharmacist's advice also includes recommendations on lifestyle measures and/or referral to a doctor who can make a decision on semi-invasive or surgical treatment.

Keywords: haemorrhoidal disease, perianal thrombosis, rectal bleeding, topical treatment for haemorrhoids, venoactive drugs, micronized purified flavonoid fraction.

Accepted: October 13, 2022; Published: October 27, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kouda M, Kroupová G. Haemorrhoidal disease or another problem? Pharmacy for Practice. 2022;18(3):151-154. doi: 10.36290/lek.2022.031.
Download citation

References

  1. Godeberge P, Sheikh P, Zagriadskiĭ E, et al. Hemorrhoidal disease and chronic venous insufficiency: Concomitance or coincidence; results of the CHORUS study (Chronic venous and HemORrhoidal diseases evalUation and Scientific research). J Gastroenterol Hepatol. 2020;35(4):577-585. Go to original source... Go to PubMed...
  2. Őrhalmi J. Hemoroidy - konzervativní, či chirurgický přístup? Med. praxi 2012;9(6-7):269-273.
  3. Vlček P, Korbička, Diviš P, et al. Co nového v léčbě hemoroidů? Med. Praxi. 2010;7(1):9-13.
  4. van Tol RR, Kleijnen J, Watson AJM, et al. European Society of ColoProctology (ESCP) Guideline for Haemorrhoidal Disease. Dostupné na: https://www.escp.eu.com/images/guidelines/documents/ESCP­‑Guidelines­‑Haemorrhoidal­‑Disease-2019-02.pdf.
  5. Seifert B, Hoch J, Zimolová P, et al. Hemoroidální nemoc. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře. Dostupné na: https://www.svl.cz/files/files/Doporucene­‑postupy/2020/DP­‑Hemoroidalni.pdf.
  6. Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I. Int Angiol. 2018;37(3):181-254. Go to original source... Go to PubMed...
  7. Šimandl O. Role systémové a lokální terapie v samoléčbě hemoroidálního onemocnění ve vztahu k jeho symptomatologii - od teorie k praxi. Prakt. lékáren. 2021;17(3):175-182. Go to original source...
  8. Tuhá K. Možnosti farmakoterapie hemoroidálnîho onemocněnî. Prakt Lékáren. 2014;10(3):102-104.
  9. Davis BR, Lee­‑Kong SA, Migaly J, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids. Dis Colon Rectum. 2018;61(3):284-292. Go to original source... Go to PubMed...
  10. Johanson JF. Nonsurgical treatment of hemorrhoids. J Gastrointest Surg. 2002;6(3):290-294. Go to original source... Go to PubMed...
  11. Lohsiriwat V. Hemorrhoids: from basic pathophysiology to clinical management. World J Gastroenterol. 2012;18(17):2009-2017. Go to original source... Go to PubMed...
  12. Madoff RD, Fleshman JW; Clinical Practice Committee, American Gastroenterological Association. American Gastroenterological Association technical review on the diagnosis and treatment of hemorrhoids. Gastroenterology. 2004;126(5):1463-1473. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.